General Information of the Compound
| Compound ID |
CP0970066
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-4'-((4-(11-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yloxy)undecyl)piperazin-1-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methylbiphenyl-3-carboxamide
Show/Hide
|
||||||||||||||||||
| Formula |
C58H75N7O8
|
||||||||||||||||||
| Molecular Weight |
998.279
|
||||||||||||||||||
| Canonical SMILES |
CCN(c1cc(-c2ccc(CN3CCN(CCCCCCCCCCCOc4cccc5c4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)cc2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C58H75N7O8/c1-5-64(45-24-32-72-33-25-45)50-36-44(35-47(41(50)4)54(67)59-37-48-39(2)34-40(3)60-55(48)68)43-20-18-42(19-21-43)38-63-29-27-62(28-30-63)26-13-11-9-7-6-8-10-12-14-31-73-51-17-15-16-46-53(51)58(71)65(57(46)70)49-22-23-52(66)61-56(49)69/h15-21,34-36,45,49H,5-14,22-33,37-38H2,1-4H3,(H,59,67)(H,60,68)(H,61,66,69)
Show/Hide
|
||||||||||||||||||
| InChIKey |
PDKKCVQIQSBADX-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound